Enalare Therapeutics Announces Partnership with BARDA to Advance Development of its Lead Product ENA-001
Enalare Therapeutics Announces Partnership with BARDA to Advance Development of its Lead Product ENA-001 Posted Apr 29, 2021 The Funding Will Accelerate Development of an Intramuscular Formulation of a Novel Agnostic Respiratory Stimulant to Treat Life-threatening Respiratory Depression PRINCETON, N.J. - Enalare Therapeutics Inc. announced today that it has received an initial contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Hum...
Source: biopharmadive.com